Ventas, Inc. (VTR) Financial Statements
Historical financial data — 41 statements covering FY2016–FY2025
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The...
Ventas, Inc.'s revenue increased 18.5% year over year, from $4.92B to $5.83B.
Net income increased 209.8% over the same period, from $81.2M to $251.4M.
Over the 9-year period from FY2016 to FY2025, revenue grew by 69% in total.
Operating cash flow grew 23.8% to $1.65B.
Ventas, Inc. maintains a moderate net profit margin of 4.3%.
Recent Financial Statements
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2023 | $3.33B+52.7% | $49.8M | $-2.6M | $-2.6M | $840.8M | $24.97B | N/A | $9.82B |
| Q1 FY2024 | $1.20B-64.0% | $-14.3M | $-7.5M | $-7.5M | $266.4M | $24.67B | N/A | $9.40B |
| Q2 FY2024 | $2.40B+100.1% | $5.1M | $-26.6M | $-26.6M | $602.3M | $24.53B | N/A | $9.62B |
| Q3 FY2024 | $3.64B+51.5% | $24.3M | $-7.5M | $-7.5M | $956.0M | $25.35B | N/A | $9.76B |
| Q1 FY2025 | $1.36B-62.7% | $46.9M | $40.9M | $40.9M | $321.1M | $26.03B | N/A | $11.47B |
| Q2 FY2025 | $2.78B+104.6% | $115.1M | $83.6M | $83.6M | $796.5M | $26.47B | N/A | $11.53B |
| Q3 FY2025 | $4.27B+53.6% | $181.2M | $128.0M | $128.0M | $1.18B | $26.93B | N/A | $12.36B |
| Q1 FY2026 | $1.66B-61.2% | $55.9M | $35.4M | $35.4M | $394.6M | $27.69B | N/A | $13.12B |
Balance Sheet Summary (Latest Period)
Total Assets
$27.59B
Total Liabilities
$14.63B
Total Equity
$12.53B
Cash & Equivalents
$741.1M
Total Debt
N/A
Current Assets
N/A
Current Liabilities
N/A
Retained Earnings
$-7.53B